Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
Bullboard Posts
User Avatar Image
(26)
•••
Post by colimaon Jun 27, 2018 7:29am
227 Views
Post# 28234746

Insiders

Insiders
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Jun 26/18 Jun 22/18 Willis, David Glenn Direct Ownership Options 50 - Grant of options 75,000 Jun 26/18 Jun 22/18 Hirson, Desmond Direct Ownership Options 50 - Grant of options 100,000 Jun 26/18 Jun 22/18 Rabinowitz, Alan Neil Direct Ownership Options 50 - Grant of options 75,000 Jun 26/18 Jun 22/18 Dalla-Longa, Danny Direct Ownership Options 56 - Grant of rights 75,000 $0.310 Jun 26/18 Jun 22/18 Segal, Donald Direct Ownership Options 50 - Grant of options 75,000 Jun 26/18 Jun 22/18 Briant, Ellen Elizabeth Direct Ownership Options 50 - Grant of options 75,000 $0.310 Apr 11/18 Apr 10/18 Adams, George Direct Ownership Common Shares 46 - Compensation for services 375,000 $0.320
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities